What is Sarepta (SRPT)?
Sarepta Therapeutics, Inc. is a biopharmaceutical company focused on the discovery and development of precision genetic medicines for rare neuromuscular diseases. The company specializes in RNA-targeted therapeutics, including antisense oligonucleotides and gene therapy approaches, aimed at treating conditions such as Duchenne muscular dystrophy and other genetic disorders. Sarepta's research and development efforts involve advancing novel platforms to address unmet medical needs with a focus on genetic mutations and mechanisms. The company collaborates with academic institutions, research organizations, and industry partners to support its pipeline development. Its operations encompass clinical development, regulatory activities, and manufacturing related to its therapeutic candidates. Sarepta is recognized for its contributions to the field of genetic medicine and its commitment to advancing treatments for rare diseases.
Sarepta Stock Price Today: Live Overview
The price today is shaped by current session dynamics with Sarepta valued at $16.77. It has seen a low of $16.47 and a high of $17.25, with a daily change of 0%.
FAQ: Sarepta (SRPT)
What is the current price of SRPT stock?
The current price stands at $16.77.
Does SRPT pay dividends?
Sarepta does not pay dividends.
Does SRPT have a formal corporate presence or regional headquarters in the UAE?
Sarepta does not have an official presence in the UAE and operates via partners only.
What is SRPT best known for?
The company is most famous for its gene therapy and RNA-targeted treatments for rare diseases.
What assets are typically shown together with SRPT?
Commonly shown alongside SRPT: Ionis Pharmaceuticals, ImmuCell, NexGen Energy Ltd
Latest shares articles



